You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DK210(EGFR)

Showing 1 - 25 of 2,231
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)

Not yet recruiting
  • Cancer
  • +8 more
  • DK210 (EGFR)
  • +3 more
  • (no location specified)
Jan 27, 2023

NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Pemetrexed)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Phoenix, Arizona
  • +303 more
Aug 17, 2022

Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations Trial in Worldwide (Neratinib, Fulvestrant, Trastuzumab)

Active, not recruiting
  • Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
  • Birmingham, Alabama
  • +59 more
Mar 3, 2022

Kidney Transplant Trial (eGFR reporting)

Recruiting
  • Kidney Transplant
  • eGFR reporting
  • Boston, Massachusetts
    Brigham and Women's
Jan 30, 2023

Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +43 more
Nov 25, 2022

NSCLC Trial in Guangdong (SI-B001, Osimertinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Guangdong, Guangzhou, China
    Sun Yat-sen University Cancer Center (SYSUCC)
Jul 31, 2022

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Puerto Rico, United States (HBI-2376)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Duarte, California
  • +11 more
Aug 23, 2022

Malignant Pleural Effusion, NSCLC Trial in Næstved (meassurement of PD-L1, ALK, EGFR)

Recruiting
  • Malignant Pleural Effusion
  • Non-small Cell Lung Cancer
  • meassurement of PD-L1, ALK, EGFR
  • Næstved, Region Sjælland, Denmark
    Næstved Sygehus, department of pulmonary medicine
May 10, 2022

NSCLC Trial in Worldwide (Amivantamab, Pemetrexed, Carboplatin)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Duarte, California
  • +228 more
Jan 31, 2023

Patients With EGFR Mutated Lung Cancer

Unknown status
  • Lung Neoplasms
    • Aarhus, DK, Denmark
      Aarhus University Hospital
    Nov 8, 2019

    NSCLC Trial (Furmonertinib)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Aug 10, 2023

    NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • MK-2870
    • +2 more
    • (no location specified)
    Oct 3, 2023

    NSCLC Trial in China (BBP-398, osimertinib)

    Recruiting
    • NSCLC
    • Beijing, Beijing, China
    • +4 more
    Sep 4, 2023

    NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Nintedanib, gefitinib, erlotinib, afatinib
    • (no location specified)
    Oct 2, 2023

    NSCLC Trial in Worldwide (Amivantamab, Osimertinib, Lazertinib)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Goodyear, Arizona
    • +266 more
    Aug 17, 2022

    NSCLC, EGFR Gene Mutation Trial in Nanjing (neo-antigen vaccine)

    Recruiting
    • NSCLC
    • EGFR Gene Mutation
    • neo-antigen vaccine
    • Nanjing, China
      The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,
    Oct 19, 2023

    NSCLC Trial in Shanghai (IN10018, Furmonertinib)

    Recruiting
    • NSCLC
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Aug 8, 2023

    Arterio-venous Fistula Trial in Kafr Ash Shaykh (suturing technique in arteriovenous fistula creation for hemodialysis)

    Recruiting
    • Arterio-venous Fistula
    • suturing technique in arteriovenous fistula creation for hemodialysis
    • Kafr Ash Shaykh, Egypt
      Kafrelsheikh University
    Oct 18, 2023

    Lung Cancer, Non-small Cell, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial in Changsha (Genomic profiles detection,

    Recruiting
    • Lung Cancer, Non-small Cell
    • +4 more
    • Genomic profiles detection
    • circulating tumor DNA detection
    • Changsha, Hunan, China
      Department of Oncology, The Second Xiangya Hospital, Central Sou
    Oct 25, 2022

    NSCLC Trial (SKB264, Pemetrexed, Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    May 23, 2023

    NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • HS-10241+ Almonertinib
    • Pemetrexed + Cisplatin /Carboplatin
    • (no location specified)
    Oct 29, 2023

    Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant

    Completed
    • The Primary Study Metric is Progression-free Survival (PFS)
      • (no location specified)
      Jun 28, 2023

      Lung Tumors Trial in Gyeonggi-do, Incheon, Seoul (lazertinib(YH25448))

      Recruiting
      • Lung Neoplasms
      • Gyeonggi-do, Korea, Republic of
      • +5 more
      Apr 19, 2022

      Cervical Cancer Trial (Nimotuzumab?Tislelizumab)

      Not yet recruiting
      • Cervical Cancer
      • (no location specified)
      Sep 9, 2023

      Lung Cancer Trial in Boston, Nashville

      Active, not recruiting
      • Lung Cancer
        • Boston, Massachusetts
        • +1 more
        Dec 28, 2022